Microbot Medical Inc. (NASDAQ:MBOT) shares traded down 6.8% during mid-day trading on Friday after an insider sold shares in the company. The stock traded as low as $1.09 and last traded at $1.09. 546,723 shares traded hands during trading, a decline of 65% from the average session volume of 1,544,750 shares. The stock had previously closed at $1.17.

Specifically, Director Moshe Shoham sold 33,700 shares of the firm’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $1.50, for a total transaction of $50,550.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Yoseph Bornstein sold 50,000 shares of the firm’s stock in a transaction dated Tuesday, September 19th. The shares were sold at an average price of $1.18, for a total value of $59,000.00. The disclosure for this sale can be found here. Insiders have sold 424,310 shares of company stock worth $520,396 in the last 90 days. Company insiders own 31.83% of the company’s stock.

The firm’s 50 day moving average price is $1.22 and its 200-day moving average price is $2.14. The stock’s market cap is $48.00 million.

Microbot Medical (NASDAQ:MBOT) last released its quarterly earnings data on Monday, August 14th. The biotechnology company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.48) by $0.44. Analysts forecast that Microbot Medical Inc. will post ($25.02) EPS for the current fiscal year.

A hedge fund recently bought a new stake in Microbot Medical stock. Sabby Management LLC acquired a new stake in shares of Microbot Medical Inc. (NASDAQ:MBOT) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned about 2.92% of Microbot Medical as of its most recent SEC filing. Institutional investors and hedge funds own 4.66% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/29/microbot-medical-inc-mbot-shares-down-6-8-on-insider-selling.html.

About Microbot Medical

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Receive News & Stock Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related stocks with our FREE daily email newsletter.